EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Clinical Analysis of Inhaled Nitric Oxide Therapy in Preterm Infants at Different Gestational Ages: A National Retrospective Multicenter Study

Klinische Analyse der inhalativen Stickstoffmonoxidtherapie bei Frühgeborenen unterschiedlichen Gestationsalters: nationale retrospektive Multizenterstudie

Guo-Bao Liang, Lian Wang, Sheng-Qian Huang, Bao-Ying Feng, Mu-Lin Yao, Xu-Fang Fan, Meng-Jiao Wang, Lu Zhu, Jing Zhang, Zhi Zheng, Yao Zhu, Wei Shen und 9 weitere

American Journal of Perinatology · 01.04.2025 · 42 (06) · 732-741

DOI: 10.1055/a-2419-0021 ↗

Auf einen Blick

Bei 434 Frühgeborenen <34 SSW in China war die iNO-Nutzung bei extrem Frühgeborenen am höchsten. Ein klinischer Nutzen unterschied sich zwischen den Gestationsaltersgruppen nicht.

Fragestellung

Welche klinischen Merkmale und Behandlungseffekte hat inhalatives Stickstoffmonoxid (iNO) bei Frühgeborenen <34 SSW in China je nach Gestationsalter?

Methode

Retrospektive Multizenterstudie mit 434 Frühgeborenen <34 SSW aus 8 tertiären Krankenhäusern in China; Zeitraum Januar 2013 bis Dezember 2022.

Ergebnisse

Die iNO-Nutzung lag bei 4,20 % bei 24 bis 27 SSW, 1,54 % bei 28 bis 31 SSW und 0,85 % bei 32 bis 33 SSW. Der therapeutische Effekt unterschied sich nicht signifikant zwischen den Gruppen. Komplikationen und Mortalität nahmen mit sinkender SSW zu.

Schlussfolgerung der Autor:innen

Bei Frühgeborenen <34 SSW war die iNO-Nutzung bei extrem Frühgeborenen am höchsten. iNO verbesserte bei extrem Frühgeborenen mit refraktärer Hypoxämie das klinische Outcome nicht; zwischen den Gestationsaltersgruppen zeigte sich kein signifikanter Unterschied im therapeutischen Effekt.

Kernaussagen

  • iNO-Nutzung: 4,20 % bei 24 bis 27 SSW am höchsten
  • Kein signifikanter Unterschied im therapeutischen Effekt zwischen den Gruppen
  • Komplikationen und Mortalität nahmen mit sinkendem Gestationsalter zu

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Perinatology, erschienen am 01.04.2025. Verfasst von Guo-Bao Liang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China. Hauptthemen laut MEDLINE: Nitric Oxide, Infant, Premature, Diseases, Respiratory Distress Syndrome, Newborn, Bronchodilator Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Project of Clinical Key Specialty of Fujian Province, Xiamen Key Laboratory of Perinatal-Neonatal Infection.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to investigate clinical features of inhaled nitric oxide (iNO) in preterm infants with a gestational age (GA) < 34 weeks in China. The clinical data of 434 preterm infants with GA < 34 weeks, treated with iNO in the neonatology departments of eight Class A tertiary hospitals in China over a 10-year period from January 2013 to December 2022, were included in this retrospective multicenter investigation. The infants were divided into three groups based on GA: 24 to 27 weeks (extremely preterm infants), 28 to 31 weeks (very preterm infants), and 32 to 33 weeks (moderate preterm infants). The use of iNO, perinatal data, incidence and mortality of indication for iNO treatment, therapeutic effects of iNO, incidence of short-term complications for iNO treatment, and mortality were compared among these three groups. Over the past 10 years, the proportion of iNO use was highest in extremely preterm infants each year. The lower the GA, the higher the iNO use rate: 4.20% for GA 24 to 27 weeks, 1.54% for GA 28 to 31 weeks, and 0.85% for GA 32 to 33 weeks. There was no significant difference in the therapeutic effect of iNO among the three groups. The incidence of neonatal pulmonary hemorrhage, neonatal shock, late-onset diseases, retinopathy of prematurity requiring intervention, intracranial hemorrhage (grade 3 or 4), periventricular leukomalacia, neonatal necrotizing enterocolitis (≥stage II), and moderate to severe bronchopulmonary dysplasia was highest in extremely preterm infants and increased with decreasing GA. Mortality was negatively correlated with GA and birth weight. The highest rate of iNO treatment in 24 to 27 weeks' preterm infants was due to hypoxic respiratory failure (HRF), whereas the highest rate of iNO treatment in 32 to 33 weeks' preterm infants was due to documented persistent pulmonary hypertension of the newborn (PPHN). The rates of iNO treatment due to HRF and documented PPHN were 54.3 and 60.6%, respectively, in extremely preterm infants, significantly higher than in very preterm and moderate preterm infants (all p < 0.05). Within the same GA group, the proportion of preterm infants treated with iNO for HRF was lower than that for documented PPHN (all p < 0.05), but there was no statistically significant difference in mortality between HRF and documented PPHN treated with iNO (all p > 0.05). Among preterm infants with GA < 34 weeks, the rate of iNO usage was highest in extremely preterm infants. However, iNO failed to improve the clinical outcome of extremely preterm infants with refractory hypoxemia, and there was no significant difference in the therapeutic effect of iNO among preterm infants with different GAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nitric OxideInfant, Premature, DiseasesRespiratory Distress Syndrome, NewbornBronchodilator AgentsHumansInfant, NewbornRetrospective StudiesAdministration, InhalationFemaleGestational AgeMaleChinaInfant, PrematureInfant, Extremely PrematureBronchopulmonary DysplasiaEnterocolitis, Necrotizing

Substanzen

Nitric OxideBronchodilator Agents

Autor:innen und Institutionen

  • Department of Neonatology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China.
  • Department of Neonatology, Guiyang Maternal and Child Health Care Hospital, Guiyang Children's Hospital, Guiyang, Guizhou, China.
  • Department of Neonatology, Maternal and Child Health Hospital of the Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.
  • Department of Neonatology, Children's Hospital of Hebei Province, Shijiazhuang, Hebei, China.
  • Department of Neonatology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Neonatology, Northwest Women's and Children's Hospital, Xi'an, Shanxi, China.

ORCID-Profile: Fa-Lin Xu

Förderung

  • Project of Clinical Key Specialty of Fujian Province
  • Xiamen Key Laboratory of Perinatal-Neonatal Infection

Zitieren

APA

Liang, G. B., Wang, L., Huang, S. Q., Feng, B. Y., Yao, M. L., Fan, X. F., Wang, M. J., Zhu, L., Zhang, J., Zheng, Z., Zhu, Y., Shen, W., Duan, W. L., Mao, J., Wu, F., Li, Z. K., Xu, F. L., Ma, L., Wei, Q. F., …, & Lin, X. Z. (2025). Clinical Analysis of Inhaled Nitric Oxide Therapy in Preterm Infants at Different Gestational Ages: A National Retrospective Multicenter Study. American Journal of Perinatology, 42(06), 732-741. https://doi.org/10.1055/a-2419-0021

Vancouver

Liang GB, Wang L, Huang SQ, Feng BY, Yao ML, Fan XF, et al. Clinical Analysis of Inhaled Nitric Oxide Therapy in Preterm Infants at Different Gestational Ages: A National Retrospective Multicenter Study. American Journal of Perinatology. 2025;42(06):732-741. doi:10.1055/a-2419-0021

BibTeX
@article{Liang2025,
  author = {Liang, Guo-Bao and Wang, Lian and Huang, Sheng-Qian and Feng, Bao-Ying and Yao, Mu-Lin and Fan, Xu-Fang and Wang, Meng-Jiao and Zhu, Lu and Zhang, Jing and Zheng, Zhi and Zhu, Yao and Shen, Wei and Duan, Wen-Li and Mao, Jian and Wu, Fan and Li, Zhan-Kui and Xu, Fa-Lin and Ma, Li and Wei, Qiu-Fen and Liu, Ling and Lin, Xin-Zhu},
  title = {Clinical Analysis of Inhaled Nitric Oxide Therapy in Preterm Infants at Different Gestational Ages: A National Retrospective Multicenter Study},
  journal = {American Journal of Perinatology},
  year = {2025},
  volume = {42},
  number = {06},
  pages = {732--741},
  doi = {10.1055/a-2419-0021}
}
Kostenlos starten →